EVALUATING THE EFFICACY OF ORAL MELATONIN IN DECREASING THE HEART RATE AND BLOOD PRESSURE TO LARYNGOSCOPY AND TRACHEAL INTUBATIO
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2022/01/039383
- Lead Sponsor
- DR VINUTHA PATIL C
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Age between 18 â?? 45 years of either sex.
2.Patients belonging to American Society of Anaesthesiologist (ASA) grade 1 and 2 patients.
Exclusion Criteria
1) Refusal to consent for study.
2) Patients Receiving treatment with the study drug (melatonin).
3) Patients with
1.Uncontrolled hypertension and diabetes.
2.Mental illness, Severe Cardiac illness and Renal or hepatic disease.
3.Pregnancy and lactation.
4.Anticipated difficult intubation [Modified Mallampati class 3 and 4]
5.Patients on Hypnotics, Sedatives, anxiolytics, anti-epileptics.
6.History of allergy to melatonin.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method